Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark

Liver Transplantation

Volumn 16, Issue 2, 2010, Pages 130-137

  McCaughan, Geoffrey W ^a   Shackel, Nicholas A ^a   Strasser, Simone I ^a   Dilworth, Pamela ^a   Tang, Patrick ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; SEPSIS;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CARCINOMA, HEPATOCELLULAR; CHILD; CHOLANGITIS, SCLEROSING; HEPATITIS C, CHRONIC; HEPATITIS, AUTOIMMUNE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER CIRRHOSIS, BILIARY; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; NEW ZEALAND; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 75449100949     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21978     Document Type: Article

References (12)

1. Evans IV, Belle SH. U.S. trends in liver transplantation, 1988 to 2001. In: Bussuttil W, Klintmalm G, eds. Transplantation of the Liver. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2005. pp 1299-1322.
2. Jain A, Reyer J, Kashyap R, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000;232:490-500.
3. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004;4:378-383.
4. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000;31:792-799.
5. Pirsch JD, Kalayoglu M, Hafez GR, D'Alessandro AM, Sollinger HW, Belzer FD. Evidence that the vanishing bile duct syndrome is vanishing. Transplantation 1990;49:1015-1018.
6. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005;80:759-764.
7. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000;69:781-789.
8. Berenguer M, Prieto M, San Juan F, Rayón JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002;36:202-210.
9. Futagawa Y, Terasaki PI, Waki K, Cai J, Gjertson DW. No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data. Am J Transplant 2006;6:1398-1406.
10. Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003;9:1231-1247.
11. Barber K, Blackwell J, Collett D, Neuberger J. Life expectancy of adult liver allograft recipients in the UK. Gut 2007;56:279-282.
12. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896.